Indian Journal of Ophthalmology (Jan 2024)

Collagen cross-linking beyond corneal ectasia: A comprehensive review

  • Grigory A Osipyan,
  • Husam Khraistin,
  • Mohammad Jourieh

DOI
https://doi.org/10.4103/IJO.IJO_1507_23
Journal volume & issue
Vol. 72, no. 14
pp. 191 – 202

Abstract

Read online

The history of corneal cross-linking (CXL) dates back to 2003 when some German scientists investigated possible treatments to harden the corneal structure to increase its resistance in ectatic corneal diseases. Nowadays, CXL is considered the most effective therapy in ectatic corneal diseases due to its proven efficacy in hardening the cornea, thus halting the development of the disease. Since 2003, CXL applications have dramatically expanded and have been implemented in several other areas such as infectious keratitis, corneal edema, and before performing keratoplasty for various purposes. Moreover, several irradiation patterns are being studied to correct refractive errors, taking into account the corneal refractive changes that occur after the procedure. Currently, scleral cross-linking is also being investigated as a potential therapy in cases of progressive myopia and glaucoma. In this article, we provide a comprehensive overview of the available applications of cross-linking in nonectatic ocular conditions and highlight the possible future indications of this procedure.

Keywords